No insider bought or sold Gemphire Therapeutics Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow GEMP

GEMP over the last year

Prices for GEMP aren't in yet.

GEMP after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

13 insider filings since 2016, newest first

GEMPBuy

Seth Reno · Chief Commercial Officer

$100K+357.0%Feb 12

GEMPBuy

P. Kent Hawryluk · Director

$237K+28.0%Mar 14

GEMPBuy

Andy Sassine · Director

$200K+18.0%Mar 14

GEMPBuy

Pedro Lichtinger · Director

$100K+21.0%Mar 14

GEMPBuy

Steven R. Ph.d. Gullans · Director

$500K+7.0%Mar 14

GEMPBuy

P. Kent Hawryluk · Director

$250K+39.0%Aug 12

GEMPBuy

Jeffrey S Mathiesen · CFO

$40K+102.0%Aug 12

GEMPBuy

Pedro Lichtinger · Director

$100K+25.0%Aug 12

GEMPBuy

Steven R. Ph.d. Gullans · Director

$5.0M+163.0%Aug 12

GEMPBuy

Seth Reno · Chief Commercial Officer

$40KAug 12

GEMPBuy

Mina Sooch · President and CEO

$525K+8.0%Aug 12

GEMPBuy

David Lowenschuss · General Counsel and Secretary

$111K+1.0%Aug 12

GEMPBuy

Charles Phd Bisgaier · Chair, Chief Scientific Office, 10%

$518K+4.0%Aug 12

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.